J9329 Injection, tislelizumab-jsgr
Also known as: tislelizumab, Beyfortus
Injection of tislelizumab-jsgr, a programmed cell death ligand 1 (PD-L1) monoclonal antibody. Immune checkpoint inhibitor.
In Plain Language
immunotherapy injection; cancer immune checkpoint drug
Clinical Context
Used for non-small cell lung cancer and other malignancies expressing PD-L1. Checkpoint inhibitor with reduced immunotoxicity profile.
RVU Information
CPT J9329 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9329?
CPT J9329 (Injection, tislelizumab-jsgr) is a J Codes (Drugs) code. Injection of tislelizumab-jsgr, a programmed cell death ligand 1 (PD-L1) monoclonal antibody. Immune checkpoint inhibitor.
How is J9329 administered?
CPT J9329 is administered by a healthcare provider, typically via injection or infusion. Used for non-small cell lung cancer and other malignancies expressing PD-L1. Checkpoint inhibitor with reduced immunotoxicity profile. It is used by Oncology, Pulmonology, Internal Medicine.
When is CPT J9329 used?
Used for non-small cell lung cancer and other malignancies expressing PD-L1. Checkpoint inhibitor with reduced immunotoxicity profile.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.